Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study.
Bianco C, Rossetti B, Gagliardini R, Lamonica S, Fanti L, Lombardi F, Cauda R, Di Giambenedetto S, De Luca A. Bianco C, et al. Among authors: di giambenedetto s. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19816. doi: 10.7448/IAS.17.4.19816. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397560 Free PMC article.
Declining HCV seroprevalence in pregnant women with HIV.
Floridia M, Tamburrini E, Anzidei G, Tibaldi C, Muggiasca ML, Guaraldi G, Fiscon M, Vimercati A, Martinelli P, Donisi A, Dalzero S, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. Floridia M, et al. Epidemiol Infect. 2010 Sep;138(9):1317-21. doi: 10.1017/S0950268810000129. Epub 2010 Jan 25. Epidemiol Infect. 2010. PMID: 20096149
Factors influencing gestational age-adjusted birthweight in a national series of 600 newborns from mothers with HIV.
Floridia M, Ravizza M, Bucceri A, Lazier L, Viganò A, Alberico S, Guaraldi G, Anzidei G, Guerra B, Citernesi A, Sansone M, Baroncelli S, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. Floridia M, et al. HIV Clin Trials. 2008 Sep-Oct;9(5):287-97. doi: 10.1310/hct0905-287. HIV Clin Trials. 2008. PMID: 18977717
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.
Zaccarelli M, Perno CF, Forbici F, Cingolani A, Liuzzi G, Bertoli A, Trotta MP, Bellocchi MC, Di Giambenedetto S, Tozzi V, Gori C, D'Arrigo R, De Longis P, Noto P, Girardi E, De Luca A, Antinori A. Zaccarelli M, et al. Among authors: di giambenedetto s. Antivir Ther. 2003 Feb;8(1):51-6. Antivir Ther. 2003. PMID: 12713064
Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.
De Luca A, Cingolani A, Di Giambenedetto S, Trotta MP, Baldini F, Rizzo MG, Bertoli A, Liuzzi G, Narciso P, Murri R, Ammassari A, Perno CF, Antinori A. De Luca A, et al. Among authors: di giambenedetto s. J Infect Dis. 2003 Jun 15;187(12):1934-43. doi: 10.1086/375355. Epub 2003 May 22. J Infect Dis. 2003. PMID: 12792870 Clinical Trial.
Interpretation systems for genotypic drug resistance of HIV-1.
De Luca A, Antinori A, Di Giambenedetto S, Cingolani A, Colafigli M, Perno CF, Cauda R. De Luca A, et al. Among authors: di giambenedetto s. Scand J Infect Dis Suppl. 2003;106:29-34. doi: 10.1080/03008870310009623. Scand J Infect Dis Suppl. 2003. PMID: 15000579 Review.
306 results